Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Has beta-blocker use increased in patients with heart failure in internal medicine settings? Prognostic implications: RICA registry.

González-García A, Montero Pérez-Barquero M, Formiga F, González-Juanatey JR, Quesada MA, Epelde F, Oropesa R, Díez-Manglano J, Cerqueiro JM, Manzano L; RICA registry investigators.

Rev Esp Cardiol (Engl Ed). 2014 Mar;67(3):196-202. doi: 10.1016/j.rec.2013.07.012. Epub 2013 Nov 9.

PMID:
24774394
2.

Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB; OPTIMIZE-HF Investigators and Coordinators.

Am Heart J. 2007 Jan;153(1):82.e1-11.

PMID:
17174643
3.

Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.

Bhatia V, Bajaj NS, Sanam K, Hashim T, Morgan CJ, Prabhu SD, Fonarow GC, Deedwania P, Butler J, Carson P, Love TE, Kheirbek R, Aronow WS, Anker SD, Waagstein F, Fletcher R, Allman RM, Ahmed A.

Am J Med. 2015 Jul;128(7):715-21. doi: 10.1016/j.amjmed.2014.11.036. Epub 2014 Dec 30.

PMID:
25554369
4.

Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.

Lund LH, Benson L, Dahlström U, Edner M, Friberg L.

JAMA. 2014 Nov 19;312(19):2008-18. doi: 10.1001/jama.2014.15241.

PMID:
25399276
5.

[How beta-blockers are used in Spain? Analysis of limitations in their use in internal medicine and cardiology: CARACTER-BETA study].

Garcia-Moll X, Fácila L, Conthe P, Zapata A, Artigas R, Bertomeu V, González-Juanatey JR; investigadores del estudio CARACTER-BETA.

Rev Esp Cardiol. 2011 Oct;64(10):883-90. doi: 10.1016/j.recesp.2011.05.023. Epub 2011 Aug 31. Spanish.

6.

Association between type-2 diabetes mellitus and post-discharge outcomes in heart failure patients: findings from the RICA registry.

Carrasco-Sánchez FJ, Gomez-Huelgas R, Formiga F, Conde-Martel A, Trullàs JC, Bettencourt P, Arévalo-Lorido JC, Pérez-Barquero MM; RICA investigators.

Diabetes Res Clin Pract. 2014 Jun;104(3):410-9. doi: 10.1016/j.diabres.2014.03.015. Epub 2014 Apr 1.

PMID:
24768593
7.

Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB; OPTIMIZE-HF Investigators and Coordinators.

J Card Fail. 2007 Nov;13(9):722-31.

PMID:
17996820
8.

Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry.

Hernandez AF, Hammill BG, O'Connor CM, Schulman KA, Curtis LH, Fonarow GC.

J Am Coll Cardiol. 2009 Jan 13;53(2):184-92. doi: 10.1016/j.jacc.2008.09.031.

9.

Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.

Philbin EF, Rocco TA Jr, Lindenmuth NW, Ulrich K, Jenkins PL.

Am J Med. 2000 Dec 1;109(8):605-13.

PMID:
11099679
11.

Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes.

Patel K, Fonarow GC, Ekundayo OJ, Aban IB, Kilgore ML, Love TE, Kitzman DW, Gheorghiade M, Allman RM, Ahmed A.

Int J Cardiol. 2014 May 15;173(3):393-401. doi: 10.1016/j.ijcard.2014.03.005. Epub 2014 Mar 11.

12.

Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed?

Franke J, Wolter JS, Meme L, Keppler J, Tschierschke R, Katus HA, Zugck C.

Clin Res Cardiol. 2013 Jan;102(1):23-31. doi: 10.1007/s00392-012-0489-2. Epub 2012 Jul 4.

PMID:
22760479
13.

Effectiveness of beta-blocker therapy in daily practice patients with advanced chronic heart failure; is there an effect-modification by age?

Dobre D, DeJongste MJ, Lucas C, Cleuren G, van Veldhuisen DJ, Ranchor AV, Haaijer-Ruskamp F.

Br J Clin Pharmacol. 2007 Mar;63(3):356-64. Epub 2006 Sep 12.

14.

Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery.

Chan AY, McAlister FA, Norris CM, Johnstone D, Bakal JA, Ross DB; Alberta Provincial Program for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):182-7, 187.e1. doi: 10.1016/j.jtcvs.2010.03.015. Epub 2010 Apr 28.

15.

Impact of home patient telemonitoring on use of β-blockers in congestive heart failure.

Antonicelli R, Mazzanti I, Abbatecola AM, Parati G.

Drugs Aging. 2010 Oct 1;27(10):801-5. doi: 10.2165/11538210-000000000-00000.

PMID:
20883060
16.

The utility of heart failure registries: a descriptive and comparative study of two heart failure registries.

Trullàs JC, Miró Ò, Formiga F, Martín-Sánchez FJ, Montero-Pérez-Barquero M, Jacob J, Quirós-López R, Herrero Puente P, Manzano L, Llorens P; members of the RICA and EAHFE registries.

Postgrad Med J. 2016 May;92(1087):260-6. doi: 10.1136/postgradmedj-2015-133739. Epub 2016 Jan 6.

PMID:
26739849
17.

Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry.

O'Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M.

J Card Fail. 2005 Apr;11(3):200-5.

PMID:
15812748
18.

Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.

Pascual-Figal DA, Redondo B, Caro C, Manzano S, Garrido IP, Ruipérez JA, Valdés M.

Am J Cardiol. 2008 Dec 15;102(12):1711-7. doi: 10.1016/j.amjcard.2008.07.059. Epub 2008 Sep 20.

PMID:
19064029
19.

Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.

Verbrugge FH, Duchenne J, Bertrand PB, Dupont M, Tang WH, Mullens W.

Am J Cardiol. 2013 Dec 15;112(12):1913-20. doi: 10.1016/j.amjcard.2013.08.013.

PMID:
24286620
20.

Characteristics of heart failure in the elderly--a hospital cohort registry-based study.

Jensen J, Hedin L, Widell C, Agnhom P, Andersson B, Fu M.

Int J Cardiol. 2008 Apr 10;125(2):191-6. Epub 2007 Oct 29.

PMID:
18029036

Supplemental Content

Support Center